Replay
10 second
10 second
Annotation
00:00 / 00:00
Merck to buy Schering-Plough in $41.1 bn deal
Drugmakers Merck & Co. and Schering-Plough Corp., already partners in a joint venture, are planning to merge under the name Merck in a stock-and-cash deal worth about $41.1 billion.
